Download FREE Report Sample
Download Free sampleLiraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
Liraglutide Market contains market size and forecasts of Liraglutide in global, including the following market information:
Global Liraglutide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Liraglutide Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Liraglutide companies in 2021 (%)
The global Liraglutide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pills Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liraglutide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liraglutide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Liraglutide Market Segment Percentages, by Type, 2021 (%)
Pills
Liquid
Global Liraglutide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Liraglutide Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Store
Global Liraglutide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Liraglutide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liraglutide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Liraglutide revenues share in global market, 2021 (%)
Key companies Liraglutide sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Liraglutide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
